EUVIMEDEUVIMED entdecken
Fallbericht

Transfer of Injected Triamcinolone into Human Milk of a Lactating Patient Suffering from Idiopathic Granulomatous Mastitis

Casey Rosen-Carole iD, Palika Datta, Kathleen Palmiter, Kerri Starks, Thomas W Hale iD

Breastfeeding Medicine · 2023

DOI: 10.1089/bfm.2022.0220 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Breastfeeding Medicine, 2023. Verfasst von Casey Rosen-Carole und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breastfeeding and Lactation Medicine, Departments of Pediatrics and OBGYN, University of Rochester, Rochester, New York, USA. Hauptthemen laut MEDLINE: Milk, Human, Granulomatous Mastitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic granulomatous mastitis (IGM) is a chronic inflammatory condition of the mammary gland that presents as a painful mass, and it must be distinguished from both infectious mastitis and breast cancer. When diagnosed during lactation, it can result in significant distress and early weaning. Injection of triamcinolone has been used as a successful treatment method, but safety in breastfed infants has not been established.

Methods

We present a case of a lactating patient who received a direct injection of triamcinolone (dosage 40 mg) in her breast to treat IGM after failure of oral corticosteroids. Breastmilk samples were expressed by the patient 0, 1, 4, and 24 hours after the procedure, and then daily for 1 week. All the samples were analyzed using liquid chromatography mass spectrometry. The patient was supported by a breastfeeding and lactation medicine clinic.

Results

After injection of triamcinolone into the granulomatous mass, breast milk samples were collected and analyzed. No samples were found to contain triamcinolone. A temporary but significant decrease in milk production was noted after injection, though only a slight decrease had been noted with 6 weeks of systemic corticosteroids. With support, the patient rebuilt milk production and continued to breastfeed from both breasts.

Conclusion

Triamcinolone was not found in any milk samples (≥0.78 ng/mL) following therapeutic injection of the affected breast. The patient was able to continue breastfeeding from the affected breast with intermittent symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanGranulomatous MastitisFemaleInfantHumansLactationBreast FeedingTriamcinoloneAdrenal Cortex HormonesImmunoglobulin M

Stichwörter der Autor:innen

breast massfistulagranulomatous mastitistriamcinoloneweaning

Substanzen

TriamcinoloneAdrenal Cortex HormonesImmunoglobulin M

Autor:innen und Institutionen

  • Division of Breastfeeding and Lactation Medicine, Departments of Pediatrics and OBGYN, University of Rochester, Rochester, New York, USA.
  • Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, Texas, USA.

ORCID-Profile: Casey Rosen-Carole, Thomas W Hale

Zitieren

APA

Rosen-Carole, C., Datta, P., Palmiter, K., Starks, K., & Hale, T. W. (2023). Transfer of Injected Triamcinolone into Human Milk of a Lactating Patient Suffering from Idiopathic Granulomatous Mastitis. Breastfeeding Medicine. https://doi.org/10.1089/bfm.2022.0220

Vancouver

Rosen-Carole C, Datta P, Palmiter K, Starks K, Hale TW. Transfer of Injected Triamcinolone into Human Milk of a Lactating Patient Suffering from Idiopathic Granulomatous Mastitis. Breastfeeding Medicine. 2023. doi:10.1089/bfm.2022.0220

BibTeX
@article{RosenCarole2023,
  author = {Rosen-Carole, Casey and Datta, Palika and Palmiter, Kathleen and Starks, Kerri and Hale, Thomas W},
  title = {Transfer of Injected Triamcinolone into Human Milk of a Lactating Patient Suffering from Idiopathic Granulomatous Mastitis},
  journal = {Breastfeeding Medicine},
  year = {2023},
  doi = {10.1089/bfm.2022.0220}
}
Kostenlos starten →